Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02545374
Other study ID # 9250
Secondary ID
Status Completed
Phase N/A
First received September 2, 2015
Last updated April 11, 2016
Start date May 2014
Est. completion date March 2016

Study information

Verified date April 2016
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Estimate in 6 months the impact of the telemedicine on the cure rate of the chronic wounds compared with the usual care(with or without CICAT-LR Network).


Recruitment information / eligibility

Status Completed
Enrollment 193
Est. completion date March 2016
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Being adult

- Taken up residence on the Languedoc-Roussillon

- Patient carrying a wound with healing or improvement objective (wound closure or the appearance of 40% of granulation)

- Informed consent signed,

- Patient member of the Security Social

- Patient having a visiting nurse.

Exclusion Criteria:

- Patient in vital or functional emergency situation during the first call or during the consultation

- Tumoral wound

- dialysis patient

- Arteritis of stage 4 and not revascularizable

- Absence of regular doctor and visiting nurse

- patient refusal

- Refusal of one of the health professionals participating in the pathology care

- Anybody incapable to communicate and to answer the questions

- Pregnant or nursing woman

- Subject deprived of freedom by court or administrative order

- Major subject protected by the law

- For the patients in telemedicine: refusal of the collaboration agreement

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Intervention

Other:
Telemedicine

Control


Locations

Country Name City State
France Wound healing Department Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of healed chronic wounds during a telemedicine care Rate of healed chronic wounds during a telemedicine care versus during a usual medical care Six months after inclusion No
Primary Rate of healed chronic wounds during a usual medical care Rate of healed chronic wounds during a telemedicine care versus during a usual medical care Six months after inclusion No
Secondary Result to the questionnaire on the quality of life: EQ-5D Compare the quality of life of patients with chronic wounds during a telemedicine coverage versus during a usual medical care, thanks to the EQ-5D quality life scale. Six months after inclusion No
Secondary A measure of the costs of the management of the disease A measure of the costs of the management of the disease (consumer care, hospitalization, transport ...) Seven months after the inclusion of the last patient No
Secondary A measure of the costs of the intervention assessed A measure of the costs of the intervention assessed (investment, maintenance, training ...). Seven months after the inclusion of the last patient No
Secondary The total healing time Six months after inclusion No
Secondary The decrease in centimeters of the wound surface to 6 months Six months after inclusion No
Secondary The response time between making an appointment and support Six months after inclusion No
Secondary The mortality rate within 6 months Six months after inclusion No